Home/About us/Our responsibilities /Communicable diseases

Communicable diseases

Our Communicable diseases unit is focused on a targeted portfolio of programs and partnerships that build on our decades of work in communicable diseases and have potential to save and improve lives.
Expand
By harnessing our deep expertise and passion for science, our team works to tackle viral and bacterial threats, creating hope for a healthier, safer world.
Collapse
From invasive E. coli disease to HIV to tuberculosis, communicable diseases are some of the most entrenched health challenges on the planet.
Focus areas
Female doctor examining petri dish at desk in medical room
Communicable diseases
Extraintestinal pathogenic E. coli (ExPEC)
May 21, 2024
Read more
Close up of lab tech transferring sample into vial
Communicable diseases
Tuberculosis
May 21, 2024
Read more
JJIM_Photo_ScientistNotes_07_3971.jpg
Communicable diseases
Leprosy
May 21, 2024
Read more
JJMTIM_Photo_PatientComfort_01_9256.jpg
Communicable diseases
HIV
May 21, 2024
Read more
Latest news
Communicable diseases & vaccines
European Commission Approves Expanded Use of HIV-1 Therapy
EDURANT® (rilpivirine) in Younger Pediatric Patients
October 28, 2024
Belgium
Read more
Communicable diseases & vaccines
U.S. FDA Approves EDURANT® PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
March 19, 2024
United States
Read more
Communicable diseases & vaccines
Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program
October 3, 2023
United States
Read more
Communicable diseases & vaccines
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
January 18, 2023
Read more
Communicable diseases & vaccines
World Health Organization Updated Emergency Use Listing Recommends Johnson & Johnson COVID-19 Vaccine for Booster Use
April 6, 2022
United States
Read more